OpenVSafe by OpenVAERS
Search V-safe

C6B-22578-73363

3 vaccinations 11 coded responses 22 check-ins 11 free-text entries 0 call cases
Sex
Male
Age at first dose
41-45
ZIP prefix
708 / LA
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-07
    Registered in v-safe
  2. 2021-01-07
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-07
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  4. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fever · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-16
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-01-21
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-27
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anxiety — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anxiety — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anxiety — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anxiety — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anxiety — Feeling: Good · Site: Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · Headache, Joint pains
    Adult check-in
  16. 2021-02-03
    Health check-in — day 7, dose 2
    Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  17. 2021-02-10
    Survey response — day 14, dose 2
    MedDRA: Rash, Urticaria — Feeling: Good
    Free text: Rash / hives on feet and anklea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-17
    Survey response — day 21, dose 2
    MedDRA: Anxiety, Arthralgia — Feeling: Good
    Free text: Continued joint pain and anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-24
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-03
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-28
    Survey response — 3 months, dose 2
    MedDRA: Weight decreased — Feeling: Good
    Free text: Weight loss
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-07-28
    Survey response — 6 months, dose 2
    MedDRA: Back pain, Disturbance in attention, Memory impairment, Muscle disorder — Feeling: Good
    Free text: Short term focus and memory issues. Back pain and loss of muscle control in legs.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  23. 2021-12-01
    Dose 3 — Pfizer-BioNTech
  24. 2022-01-27
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in
  25. 2022-06-01
    Survey response — 6 months, dose 3
    MedDRA: Feeling abnormal, Malaise, Pain — Feeling: Fair
    Free text: I don't feel right. I have. A lot of body aches and overall general malaise that I didn't have before the vaccine. Overall, I feel like someone 20 years older than I am. Although it's too late, I am having second thoughts about getting any vaccines.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-12-01
    Survey response — 12 months, dose 3
    MedDRA: Skin disorder — Feeling: Fair
    Free text: Skin issues in scalp
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-07Pfizer-BioNTech
22021-01-27Pfizer-BioNTech
32021-12-01Pfizer-BioNTech No

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-28

Systemic reaction (other): Anxiety

Release 3 — days 1–6 daily, dose 2

2021-01-29

Systemic reaction (other): Anxiety

2021-01-30

Systemic reaction (other): Anxiety

2021-01-31

Systemic reaction (other): Anxiety

2021-02-01

Systemic reaction (other): Anxiety

Release 4 — day 14, dose 2

2021-02-10

Symptoms: Rash / hives on feet and anklea

Release 4 — day 21, dose 2

2021-02-17

Symptoms: Continued joint pain and anxiety

Release 8 — 3 months, dose 2

2021-04-28

Symptoms: Weight loss

Release 9 — 6 months, dose 2

2021-07-28

Symptoms: Short term focus and memory issues. Back pain and loss of muscle control in legs.

Release 11 — 6 months, dose 3

2022-06-01

Symptoms: I don't feel right. I have. A lot of body aches and overall general malaise that I didn't have before the vaccine. Overall, I feel like someone 20 years older than I am. Although it's too late, I am having second thoughts about getting any vaccines. cut off by CDC

Release 12 — 12 months, dose 3

2022-12-01

Symptoms: Skin issues in scalp

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety ✓ ✓ ✓
SDArthralgia ✓ ✓ ✓
SDBack pain ✓ · ✓
SDDisturbance in attention ✓ · ✓
SDFeeling abnormal · · ✓
SDMalaise · · ✓
SDMemory impairment ✓ · ✓
SDMuscle disorder ✓ · ✓
SDPain · · ✓
SDRash ✓ ✓ ✓
SDSkin disorder · · ✓
SDUrticaria ✓ ✓ ✓
SDWeight decreased ✓ ✓ ✓
SROAnxiety ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release